ESR1 and breast carcinoma: In addition, THP increases the sensitivity of ER alpha (+) BCa cells to tamoxifen and fulvestrant, which are the inhibitors of antiestrogen and are applied to patients with ERα-positive breast cancer (Xia et al., 2020).